Personal Care Products

Flora Growth

Flora Growth released FY2025 Q3 earnings on November 5, 2025 (EST), actual revenue USD 9.748 M (forecast USD 12.52 M), actual EPS USD -9.0495 (forecast USD -2.13)

Flora Growth released FY2025 9 Months Earnings on November 5 (EST), actual revenue USD 36.33 M, actual EPS USD -5.9446

Flora Growth Secures Funding and Announces AI Strategy, Stock Rises

Flora Growth released FY2025 Q2 earnings on August 1 (EST), actual revenue USD 0 (forecast USD 11.77M), actual EPS USD 0 (forecast USD -2.34)

Flora Growth released FY2025 Semi-Annual earnings on August 1, 2025 (EST) with actual revenue of USD 26.58 M and EPS of USD -6.24

Flora Growth Corp. Has Low P/S Ratio Due to Revenue Decline

Flora Holdings Acquires Key Assets of MC Clinic Holdings

Flora Growth released FY2025 Q1 earnings on May 13 (EST), actual revenue USD 11.79 M (forecast USD 14.79 M), actual EPS USD -0.04 (forecast USD -0.16)

Flora Growth Corp Expected to Report EPS of 3 Cents in Q4 2025

Flora Growth Corp. Releases Q4 2024 Financial Report with Net Loss Reduced to $15.9 Million

Flora Growth released FY2024 Q4 earnings on March 24 (EST), actual revenue $13.33M USD (forecast $13.51M USD), actual EPS -$0.4243 USD (forecast -$0.17 USD)

Flora Growth released FY2024 Annual Earnings on March 24 (EST), actual revenue USD 59.51 M (forecast USD 59.69 M), actual EPS USD -50.7 (forecast USD -1.08)

Flora Growth released FY2024 Q3 earnings on November 13 Pre-Market (EST), actual revenue USD 7.238 M (forecast USD 16.75 M), actual EPS USD -11.1099 (forecast USD -3.51)

Flora Growth released FY2024 9 Months Earnings on November 13 Pre-Market (EST), actual revenue USD 25.27 M, actual EPS USD -25.9299

Flora Growth to Release FY2024 Q3 Earnings on November 14, Pre-Market EST; Forecast Revenue 16.75 M USD, EPS -0.09 USD

Flora Growth and Blossom Genetics Reach Strategic Supply Agreement to Supply Medical Cannabis to Germany

Flora Growth released FY2024 Semi-Annual earnings on August 12 Pre-Market EST, actual revenue USD 20.98 M, actual EPS USD -22.2114

Flora Growth released FY2024 Q2 earnings on August 12 Pre-Market (EST), actual revenue USD 0 (forecast USD 20.74 M), actual EPS USD 0 (forecast USD -1.755)

Flora Growth released FY2024 Q1 earnings on May 14 During-Market EST, actual revenue USD 18.03 M (forecast USD 19.04 M), actual EPS USD -14.8199 (forecast USD -0.22)

Flora Growth Acquires TruHC for $6.4 Million, Anticipating Germany's Cannabis Market Potential Over $10 Billion

Mega Fortune

Processa Pharmaceuticals

cbdMD

Agape ATP

VYNE Therapeutics

Andersen

Inspirato

Medline Inc.

Creative Global Tech

GCI LIBERTY INC COM USD0.01 SER C SUBS RTS 17/12/2025

L'Oréal S.A.

Beiersdorf

Kao Corporation

ELF Beauty

Interparfums

Oddity Tech

Nu Skin

Yatsen

Natures Sunshine

USANA Health Sciences

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap